Clinical Trials Browser

Phase 2 × Carcinoma, Hepatocellular × HuMax-IL8 × Clear all

NCT04050462 2025-10-16

Nivolumab Combined With BMS-986253 in HCC Patients

Phase 2 Terminated

13 enrolled 13 charts

Gastrointestinal

Carcinoma, Hepatocellular